Personalized Prediction of Short- and Long-Term PTH Changes in Maintenance Hemodialysis Patients

Personalized Prediction of Short- and Long-Term PTH Changes in Maintenance Hemodialysis Patients

Background: Personalized management of secondary hyperparathyroidism is a critical part of hemodialysis patient care. We used a mathematical model of parathyroid gland (PTG) biology to predict (1) short-term peridialytic intact PTH (iPTH) changes in response to diffusive calcium (Ca) fluxes and (2)...

Full description

Bibliographic Details
Main Authors:	Markus Pirklbauer, David A. Bushinsky, Peter Kotanko, Gudrun Schappacher-Tilp
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-09-01
Series:	Frontiers in Medicine
Subjects:	precision medicine secondary hyperparathyroidism parathyroid hormone patient-level prediction model hemodialysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.704970/full

Similar Items

Serum calcium and phosphorus levels in patients undergoing maintenance hemodialysis: A multicentre study in Korea
by: Gheun-Ho Kim, et al.
Published: (2014-03-01)

Risk factors for intracerebral hemorrhage in patients undergoing maintenance hemodialysis
by: Song Yu-Huan, et al.
Published: (2023-03-01)

Pharmacokinetics of evocalcet in secondary hyperparathyroidism patients receiving hemodialysis: first-in-patient clinical trial in Japan
by: Shigematsu T, et al.
Published: (2018-09-01)

Еffectiveness of long-term cinacalcet administration in hemodialysis patients with secondary hyperparathyroidism: A prospective, historically controlled study
by: O.M. Loboda, et al.
Published: (2021-12-01)

Chronic inflammation in hemodialysis patients with secondary hyperparathyroidism
by: I.O. Dudar, et al.
Published: (2022-06-01)

Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study
by: Kyubok Jin, et al.
Published: (2018-06-01)

The Efficacy of Oral Ergocalciferol on Changes in Parathyroid Hormone (iPTH) and One-Year Survival and Hemodialysis Factors of Patients with Chronic Renal Failure and Vitamin D Deficiency under Hemodialysis
by: Aria Jenabi, et al.
Published: (2019-05-01)

Editorial: Parathyroid disorders: updates of PTH/serum Ca2+ regulation and therapeutic prospects
by: Fan Zhang, et al.
Published: (2024-01-01)

Titin-mediated thick filament activation stabilizes myofibrils on the descending limb of their force–length relationship
by: Gudrun Schappacher-Tilp
Published: (2018-07-01)

The Current Role of Parathyroid Fine-Needle Biopsy (P-FNAB) with iPTH-Washout Concentration (iPTH-WC) in Primary Hyperparathyroidism: A Single Center Experience and Literature Review
by: Łukasz Obołończyk, et al.
Published: (2022-01-01)

Low Parathyroid Hormone Versus Secondary Hyperparathyroidism and Survival in Patients Undergoing Hemodialysis: A Propensity-Matched Analysis
by: Wang Guo, et al.
Published: (2022-05-01)

Laboratory criteria for the persistence of secondary hyperparathyroidism in patients with chronic kidney disease
by: M. Urina, et al.
Published: (2020-11-01)

Selective vitamin D receptor activator Paricalcitol and its potential benefits in hemodialysis patients with secondary hyperparathyroidism
by: L. V. Egshatyan
Published: (2022-06-01)

Recurrence hyperparathyroidism caused by synchronous parathyroid carcinoma and parathyromatosis in a patient with long-term hemodialysis
by: Jun Yang, et al.
Published: (2023-10-01)

Long-term treatment of evocalcet in hemodialysis patients with secondary hyperparathyroidism: a five-year prospective cohort study in 147 Japanese patients
by: Nobuo Nagano, et al.
Published: (2024-03-01)

Total parathyroidectomy with forearm autotransplantation in treatment of secondary hyperparathyroidism
by: LI Rongguo, ZHANG Weijun, XU Tingyan, DU Qiwei
Published: (2022-07-01)

Parathyroid Hormone: A Uremic Toxin
by: Eduardo J. Duque, et al.
Published: (2020-03-01)

Single-Center Experience of Parathyroidectomy Using Intraoperative Parathyroid Hormone Monitoring
by: Seong Hoon Kim, et al.
Published: (2022-10-01)

Primary hyperparathyroidism with PTH values within the reference range: clinical case of a patient with recurrent nephrolithiasis
by: Olga O. Golounina, et al.
Published: (2019-12-01)

Circulating forms of parathyroid hormone detected with an immunofluorometric assay in patients with primary hyperparathyroidism and in hyperparathyroidism secondary to chronic renal failure
by: I.S. Kunii, et al.
Published: (2001-12-01)

Refractory hypercalcemia due to an ectopic mediastinal parathyroid gland in a hemodialysis patient: a case report
by: Yingjing Shen, et al.
Published: (2019-05-01)

Microwave ablation of hyperplastic parathyroid glands is a treatment option for end-stage renal disease patients ineligible for surgical resection
by: Li Zhuo, et al.
Published: (2019-01-01)

Peripheral giant cell granuloma as a sign of hyperparathyroidism in a patient under hemodialysis: A case report and review of literature
by: Marzieh Yousefian, et al.
Published: (2023-08-01)

Usefulness of a rapid immunometric assay for intraoperative parathyroid hormone measurements
by: M.N. Ohe, et al.
Published: (2003-06-01)

Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries
by: Douglas S. Fuller, et al.
Published: (2019-05-01)

The deceptive concept of hypoparathyroidism and recurrence after parathyroidectomy in dialysis patients: are we offering a Procrustean bed to some patients?
by: FABIO LUIZ DE MENEZES MONTENEGRO, et al.

Functioning lipoadenoma of parathyroid gland
by: Okleh Akram, et al.
Published: (2012-01-01)

Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients
by: Jiao Zuo, et al.
Published: (2023-05-01)

Efficacy of low-dose cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: a single-center study
by: Gojaseni P, et al.
Published: (2017-02-01)

DIAGNOSIS AND TREATMENT OF PRIMARY HYPERPARATHYROIDISM: CLINICAL CASE
by: Martinkevich O. N., et al.
Published: (2019-08-01)

Case Report: Nine-year-old with parathyroid adenoma within the piriform sinus
by: Anna Zenno, et al.
Published: (2023-05-01)

Evaluation of Parathyroid Hormone Increase After Parathyroidectomy in Primary Hyperparathyroidism
by: Muhammet Fikri Kundes, et al.
Published: (2020-06-01)

Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial
by: Sawalmeh O, et al.
Published: (2018-01-01)

Applicability of transoral endoscopic parathyroidectomy through vestibular route for primary sporadic hyperparathyroidism: A South Indian experience
by: P R K Bhargav, et al.
Published: (2019-01-01)

Intraoperative parathyroid hormone monitoring in guiding adequate parathyroidectomy
by: Aabid Hassan Naik, et al.
Published: (2018-01-01)

High dose ESAs are associated with high iPTH levels in hemodialysis patients with end-stage kidney disease: a retrospective analysis
by: Lan eChen, et al.
Published: (2015-11-01)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019-06-01)

Clinical Characteristics of Patients with Diabetic Nephropathy on Maintenance Hemodialysis: A Multicenter Cross-sectional Survey in Anhui Province, Eastern China
by: Hu Chen, et al.
Published: (2016-01-01)

Comparison of Paricalcitol (I.V) and Alfacalcidol (I.V) in Treatment of Secondary Hyperparathyroidism (SHPT) in Hemodialysis Patients
by: Mansoor Abbas Qaisar, et al.
Published: (2020-12-01)

Advances in the treatment of secondary and tertiary hyperparathyroidism
by: Li-Xi Zhang, et al.
Published: (2022-12-01)